Authors:
Sdringola, S
Assali, AR
Ghani, M
Moustapha, A
Achour, H
Yusuf, SW
Fujise, K
Rosales, O
Schroth, GW
Anderson, HV
Smalling, RW
Citation: S. Sdringola et al., Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention, CATHET C IN, 54(3), 2001, pp. 318-324
Authors:
Cannon, CP
Battler, A
Brindis, RG
Cox, JL
Ellis, SG
Every, NR
Flaherty, JT
Harrington, RA
Krumholz, HM
Simoons, ML
Van de Werf, FJJ
Weintraub, WS
Mitchell, KR
Morrisson, SL
Brandis, RG
Anderson, HV
Cannom, DS
Chitwood, WR
Cigarroa, JE
Collins-Nakai, RL
Ellis, SG
Gibbons, RJ
Grover, FL
Heidenreich, PA
Khandheria, BK
Knoebel, SB
Krumholz, HL
Malenka, DJ
Mark, DB
McKay, CR
Passamani, ER
Radford, MJ
Riner, RN
Schwartz, JB
Shaw, RE
Shemin, RJ
Van Fossen, DB
Verrier, ED
Watkins, MW
Phoubandith, DR
Furnelli, T
Citation: Cp. Cannon et al., American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee), J AM COL C, 38(7), 2001, pp. 2114-2130
Authors:
Moustapha, A
Assali, AR
Sdringola, S
Vaughn, WK
Fish, RD
Rosales, O
Schroth, G
Krajcer, Z
Smalling, RW
Anderson, HV
Citation: A. Moustapha et al., Percutaneous and surgical interventions for in-stent restenosis: Long-termoutcomes and effect of diabetes mellitus, J AM COL C, 37(7), 2001, pp. 1877-1882
Authors:
Anderson, HV
McNatt, J
Clubb, FJ
Herman, M
Maffrand, JP
DeClerck, F
Ahn, C
Buja, LM
Willerson, JT
Citation: Hv. Anderson et al., Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries, CIRCULATION, 104(19), 2001, pp. 2331-2337
Authors:
Assali, AR
Salloum, J
Sdringola, S
Moustapha, A
Ghani, M
Hale, S
Schroth, G
Fujise, K
Anderson, HV
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban), AM J CARD, 88(8), 2001, pp. 884
Authors:
Sdringola, S
Assali, A
Ghani, M
Yepes, A
Rosales, O
Schroth, GW
Fujise, K
Anderson, HV
Smalling, RW
Citation: S. Sdringola et al., Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon, CATHET C IN, 51(4), 2000, pp. 394-399
Authors:
Assali, AR
Sdringola, S
Ghani, M
Denkats, AE
Yepes, A
Hanna, GP
Schroth, G
Fujise, K
Anderson, HV
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon, CATHET C IN, 51(1), 2000, pp. 27-31
Authors:
Assali, AR
Sdringola, S
Ghani, M
Westbrook, LA
Anderson, HV
Schroth, G
Fujise, K
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban, J INVAS CAR, 12(9), 2000, pp. 460-463
Citation: Hv. Anderson, Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: Ready for prime time, J INVAS CAR, 12(3), 2000, pp. 140-141
Authors:
Fujise, K
Yhip, PA
Anderson, HV
Schroth, G
Rosales, O
Smalling, RW
Citation: K. Fujise et al., Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure, J INTERV CA, 13(4), 2000, pp. 223-229
Citation: Hv. Anderson et al., One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies inunstable angina and non-Q wave myocardial infarction (vol 26, pg 1643, 1995), J AM COL C, 35(1), 2000, pp. 263-263
Citation: Hv. Anderson et Ba. Carabello, Provisional versus routine stenting - Routine stenting is here to stay, CIRCULATION, 102(24), 2000, pp. 2910-2914
Authors:
Anderson, HV
Stokes, MJ
Leon, M
Abu-Halawa, SA
Stuart, Y
Kirkeeide, RL
Citation: Hv. Anderson et al., Coronary artery flow velocity is related to lumen area and regional left ventricular mass, CIRCULATION, 102(1), 2000, pp. 48-54
Citation: Jt. Willerson et Hv. Anderson, Experimental models useful in evaluating myocardial viability, MYOCARDIAL VIABILITY: A CLINICAL AND SCIENTIFIC TREATISE, 2000, pp. 79-90
Authors:
Hanna, GP
Yhip, P
Fujise, K
Schroth, GW
Rosales, OR
Anderson, HV
Smalling, RW
Citation: Gp. Hanna et al., Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon, CATHET C IN, 48(3), 1999, pp. 275-278
Authors:
Jang, IK
Brown, DFM
Giugliano, RP
Anderson, HV
Losordo, D
Nicolau, JC
Dutra, OP
Bazzino, O
Viamonte, VM
Norbady, R
Liprandi, AS
Massey, TJ
Dinsmore, R
Schwarz, RP
Citation: Ik. Jang et al., A multicenter, randomized study of argatroban versus heparin as adjunct totissue plasminogen activator (TPA) in acute myocardial infarction: Myocardial infarction with novastan and TPA (MINT) study, J AM COL C, 33(7), 1999, pp. 1879-1885
Authors:
Blankenship, JC
Krucoff, MW
Werns, SW
Anderson, HV
Landau, C
White, HJ
Green, CL
Spokojny, AM
Bach, RG
Raymond, RE
Pinkston, J
Rawert, M
Talley, JD
Citation: Jc. Blankenship et al., Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty, AM J CARD, 83(5), 1999, pp. 675-680
Authors:
Scirica, BM
Moliterno, DJ
Every, NR
Anderson, HV
Aguirre, FV
Granger, CB
Lambrew, CT
Rabbani, LE
Sapp, SK
Booth, JE
Ferguson, JJ
Cannon, CP
Citation: Bm. Scirica et al., Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry, AM HEART J, 138(6), 1999, pp. 1065-1072